Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1465–1488 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension
Interventions: 15 mg sodium nitrite inhalation solution, 90 mg sodium nitrite inhalation solution, 45 mg sodium nitrite inhalation solution, 120 mg sodium nitrite inhalation solution, 25% MTD sodium nitrite inhalation solution; Drug
Lead sponsor: Aires Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 56 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Melanoma
Interventions: Nilotinib, DTIC; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 14
States / cities: Duarte, California • La Jolla, California • Los Angeles, California + 11 more

Conditions: Constipation, Bloating
Interventions: Dietary supplement for digestive health, placebo capsule; Dietary Supplement
Lead sponsor: University of Memphis; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Middle-ear Barotrauma
Interventions: flight/diving simulation, ET function testing at ambient pressure, nasal video-endoscopy; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 10 Years to 50 Years
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Alcohol Dependence
Interventions: Naltrexone 50 Mg, Placebo; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 70 Years
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 2
States / cities: Charleston, South Carolina

Conditions: Herpes Zoster, Shingles, Genital Herpes
Interventions: Valacyclovir Hydrochloride; Drug
Lead sponsor: Roxane Laboratories; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Dexpramipexole, Dexpramipexole Placebo, Moxifloxacin; Drug
Lead sponsor: Knopp Biosciences; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: HIV Infections, Sexually Transmitted Diseases
Interventions: Many Men, Many Voices (3MV); Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 341 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Emotional Disturbance
Interventions: On Track; Behavioral
Lead sponsor: Oregon Social Learning Center; Other
Eligibility: 10 Years to 15 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Sarcoma, Refractory Sarcoma
Interventions: Pazopanib, Irinotecan, Temozolomide; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 6 Years to 30 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 3
States / cities: Oakland, California • San Francisco, California • Boston, Massachusetts

Conditions: Allergic Rhinitis, Asthma, Allergy
Interventions: Broccoli Sprouts, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Gonorrhea
Interventions: zoliflodacin, ceftriaxone, azithromycin; Drug
Lead sponsor: Global Antibiotics Research and Development Partnership; Other
Eligibility: 12 Years and older
Enrollment: 1,011 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 6
States / cities: Birmingham, Alabama • San Francisco, California • Indianapolis, Indiana + 2 more

Conditions: Pertrochanteric Hip Fracture
Interventions: Short versus long cephalomedullary Intramedullary nail; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Mastectomy, Breast Reconstruction
Interventions: Flex HD Pliable Perforated HADM; Other
Lead sponsor: Musculoskeletal Transplant Foundation; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Mountain View, California • San Jose, California

Conditions: ACL Injury
Interventions: HMB, Placebo; Dietary Supplement
Lead sponsor: Metabolic Technologies Inc.; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Ames, Iowa

Conditions: Alzheimer Disease
Interventions: Memesto; Device
Lead sponsor: Edgewater Safety Systems, Inc.; Industry
Eligibility: Not listed
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Treatment, Active Control, Schizophrenia, Psychosis, Schizoaffective Disorder, Psychotic Depression, Psychotic Mood Disorders, Psychotic Disorders, Psychotic Episode, Cognitive Impairment
Interventions: Structured Cognitive Training & PRIME, Computer Games Control & PRIME; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 60 Years
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 2
States / cities: San Francisco, California • Minneapolis, Minnesota

Conditions: Respiratory Syncytial Virus
Interventions: Not listed
Lead sponsor: MedImmune LLC; Industry
Eligibility: Up to 6 Months
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 5
States / cities: San Diego, California • Lake City, Florida • Woburn, Massachusetts + 2 more

Conditions: Penicillin Allergy
Interventions: Penicillin Allergic Risk Stratification Best Practice Alert; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 2,052 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Healthy
Interventions: SPY002-072, Placebo; Drug · Other
Lead sponsor: Spyre Therapeutics, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Cypress, California

Conditions: Nephrotic Syndrome
Interventions: Prednisolone; Drug
Lead sponsor: All India Institute of Medical Sciences; Other
Eligibility: 1 Year to 4 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 4
States / cities: Los Angeles, California • Stanford, California • Ann Arbor, Michigan + 1 more

Conditions: Atrial Septal Defect, Ventricular Septal Defect, Pain, Procedural
Interventions: Regional Anesthesia, Wound infiltration, Ropivacaine 0.2% Injectable Solution; Procedure · Drug
Lead sponsor: Duke University; Other
Eligibility: Up to 17 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Leukemia
Interventions: cyclophosphamide, methotrexate, allogeneic bone marrow transplantation, iodine I 131 monoclonal antibody BC8, radiation therapy; Drug · Procedure · Radiation
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 2 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2001
U.S. locations: 2
States / cities: Seattle, Washington

Conditions: Hand Injuries, Trauma, Hand Injuries and Disorders
Interventions: Postoperative phone call; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Search by objective public record fields.

Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects

A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation

Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women

Gas Supply, Demand and Middle Ear Gas Balance -- Fly/Dive Simulation

Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions

Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)

Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM

Students, Parents, and Teachers On Track: Intervention Development for Youth With Emotional Disturbance

PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma

Effects of Whole Sprouts on Airway Allergic Inflammation

Zoliflodacin in Uncomplicated Gonorrhoea

Short Versus Long Cephalomedullary Nailing of Pertrochanteric Hip Fractures: A Randomized Prospective Study

Evaluation of a Human Acellular Dermal Matrix in Post Mastectomy Reconstruction

Effects of HMB Supplementation on Recovery Following ACL Surgery

Memesto Wearable Device for Persons With Dementia

Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)

Respiratory Events Among Premature Infants

The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal

A Study of SPY002-072 in Healthy Volunteers

Prednisolone Trial in Children Younger Than 4 Years

Regional Anesthesia Following Pediatric Cardiac Surgery

Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia

The Effects of Postoperative Physician Phone Calls for Hand and Wrist Fractures